Skip to main content
. 2016 Dec 16;3(1):e000168. doi: 10.1136/lupus-2016-000168

Figure 1.

Figure 1

Prevalence of non-specific ST-T abnormalities and corrected QT-interval (QTc) duration in systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). (A) Mean prevalence and 95% CI of non-specific ST-T abnormalities in patients with SLE versus patients with RA in univariable analysis: 44% (32% to 56%) versus 17% (10% to 24%); OR=3.8 (1.8–7.7). *Adjusted for age and antimalarial use: 56% (40% to 71%) versus 17% (8% to 26%); OR=7.8 (2.4–25.8). (B) Mean QTc length and 95% CI in SLE versus RA in univariable analysis: 467 (455–478) versus 444 (438–449). **Adjusted for age, sex and aspirin use: 465 (451–480) versus 439 (432–446).